SCHEMBL29640339

SCHEMBL29640339

CCCCCCCCCCCC(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ACE P12821 2/20 0.64
ECE1 P42892 12/20 0.60
CCKAR P32238 1/20 0.57
CCKBR P32239 1/20 0.57
OPRD1 P41143 1/20 0.57
ALOX15 P16050 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29674960 1.00 ACE (0.64) ACEECE1CCKARCCKBROPRD1
SCHEMBL29429277 1.00 ACE (0.64) ACEECE1CCKARCCKBROPRD1
SCHEMBL29429278 1.00 ACE (0.64) ACEECE1CCKARCCKBROPRD1
SCHEMBL29429279 0.94 CCKAR (0.61) ACEECE1CCKARCCKBROPRD1
SCHEMBL29674821 0.94 CCKAR (0.61) ACEECE1CCKARCCKBROPRD1
SCHEMBL28478871 0.92 ACE (0.64) ACEECE1ALOX15
SCHEMBL25264926 0.92 MEN1 (0.64) ACEALOX15
SCHEMBL25264480 0.92 MEN1 (0.64) ACEALOX15
SCHEMBL21001123 0.92 MEN1 (0.64) ACEALOX15
SCHEMBL25189279 0.92 MEN1 (0.64) ACEALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114846108-B Anti-pollution material 日产化学株式会社 2024-08-20 CN disclosed
US-20240116979-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE NISSAN CHEMICAL CORPORATION (JP) 2024-04-11 US disclosed
US-20240067675-A1 METHOD FOR PRODUCING LIPID PEPTIDE NISSAN CHEMICAL CORPORATION (JP) 2024-02-29 US disclosed
US-20230404888-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER NISSAN CHEMICAL CORPORATION (JP) 2023-12-21 US disclosed
EP-4265629-A1 METHOD FOR PRODUCING LIPID PEPTIDE Nissan Chemical Corporation (JP) 2023-10-25 EP disclosed
US-11771645-B2 Transdermally absorbable base material containing lipid peptide compound KYUSHU UNIVERSITY (JP) 2023-10-03 US disclosed
CN-116744892-A Compositions comprising a lipid peptide and a sucrose ester 日产化学株式会社 2023-09-12 CN disclosed
CN-116648455-A Method for preparing lipid peptide 日产化学株式会社 2023-08-25 CN disclosed
EP-4230265-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER Nissan Chemical Corporation (JP) 2023-08-23 EP disclosed
CN-116615435-A Method for preparing lipid peptide 日产化学株式会社 2023-08-18 CN disclosed
EP-3251656-B1 MOISTURIZING BASE MATERIAL INCLUDING LIPID-PEPTIDE COMPOUND UNIV KYUSHU (JP) 2023-07-05 EP disclosed
US-20230062111-A1 ANTI-POLLUTION MATERIAL NISSAN CHEMICAL CORPORATION (JP) 2023-03-02 US disclosed
EP-3881823-B1 SOLID BASE MATERIAL CONTAINING LIPID PEPTIDE COMPOUND NISSAN CHEMICAL CORP (JP) 2023-01-25 EP disclosed
EP-4074380-A1 ANTI-POLLUTION MATERIAL Nissan Chemical Corporation (JP) 2022-10-19 EP disclosed
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound KYUSHU UNIVERSITY (JP) 2022-09-27 US disclosed
CN-114846108-A Anti-pollution material 日产化学株式会社 2022-08-02 CN disclosed
WO-2022138957-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE 日産化学株式会社 2022-06-30 WO disclosed
WO-2022138953-A1 METHOD FOR PRODUCING LIPID PEPTIDE 日産化学株式会社 2022-06-30 WO disclosed
EP-4014958-A1 COATING FILM-FORMING COMPOSITION Nissan Chemical Corporation (JP) 2022-06-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230404888-A1 COMPOSITION CONTAINING LIPID PEPTIDE AND SUCROSE ESTER CUTA, SCAMP3, SURF4 ACE 4333/4885ECE1 1739/4885CCKAR 3952/4885
US-20240067675-A1 METHOD FOR PRODUCING LIPID PEPTIDE VIP, NGLY1, NPPA ACE 604/4885ECE1 2297/4885CCKAR 357/4885
US-20230062111-A1 ANTI-POLLUTION MATERIAL PLIN3, CUTA, PLIN5 ACE 4040/4885ECE1 3596/4885CCKAR 3704/4885
US-20240116979-A1 METHOD FOR PRODUCING LIPIDIC PEPTIDE NPPA, VIP, NGLY1 ACE 315/4885ECE1 1240/4885CCKAR 279/4885
US-11771645-B2 Transdermally absorbable base material containing lipid peptide compound NGLY1, NR1H4, HRH1 ACE 4097/4885ECE1 1457/4885CCKAR 127/4885
US-11452688-B2 Transdermally absorbable base material containing lipid peptide compound NGLY1, NR1H4, HRH1 ACE 4097/4885ECE1 1457/4885CCKAR 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.